Distribution analysis of S-222611 in brain metastases of HER2-positive breast cancer by quantitative imaging mass spectrometry: prospect for antitumor activity of EGFR/HER2/HER4 kinase inhibitor S-222611 against brain metastases

被引：0
|
作者：
Tanaka, Yukari
Hirata, Michinari
Shinonome, Satomi
Matsumoto, Mitsunobu
Nogami, Wataru
Torii, Mikinori
Nezasa, Ken-ichi
Tanaka, Hidekazu
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4085
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
    Nadia Harbeck
    Eva Ciruelos
    Guy Jerusalem
    Volkmar Müller
    Naoki Niikura
    Giuseppe Viale
    Rupert Bartsch
    Christian Kurzeder
    Michaela J. Higgins
    Roisin M. Connolly
    Sally Baron-Hay
    María Gión
    Valentina Guarneri
    Giampaolo Bianchini
    Hans Wildiers
    Santiago Escrivá-de-Romaní
    Manoj Prahladan
    Helen Bridge
    Nataliya Kuptsova-Clarkson
    Nana Scotto
    Sunil Verma
    Nancy U. Lin
    Nature Medicine, 2024, 30 (12) : 3780 - 3780
  • [42] LCCC 1025: A phase II study evaluating the mTOR inhibitor everolimus with trastuzumab and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
    Anders, Carey K.
    Deal, Allison Mary
    Dees, Elizabeth Claire
    Irvin, William Johnson
    Muss, Hyman Bernard
    Noe, Jeanne
    Karginova, Olga
    Adamo, Barbara
    Prat, Aleix
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study
    Lin, Nancy U.
    Pegram, Mark
    Sahebjam, Solmaz
    Ibrahim, Nuhad
    Fung, Anita
    Cheng, Anna
    Nicholas, Alan
    Kirschbrown, Whitney
    Kumthekar, Priya
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (24) : 2667 - +
  • [44] Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis
    Wang, Yan
    Xu, Hangcheng
    Han, Yiqun
    Wu, Yun
    Wang, Jiayu
    CANCERS, 2022, 14 (14)
  • [45] A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB)-01,-02, and-03
    Hurvitz, S. A.
    Modi, S.
    Li, W.
    Park, Y. H.
    Chung, W.
    Kim, S-B.
    Cortes, J.
    Yamashita, T.
    Pedrini, J.
    Im, S-A.
    Tseng, L-M.
    Harbeck, N.
    Krop, I.
    Curigliano, G.
    Mathias, E.
    Cathcart, J.
    Cagnazzo, A.
    Ashfaque, S.
    Egorov, A.
    Andre, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S335 - S336
  • [46] Comparing two methods of assessing response to systemic therapy in HER2-positive breast cancer brain metastases: a post hoc analysis from the TUXEDO-1 trial
    Bartsch, R.
    Furtner, J.
    Puhr, R.
    Bergmeister-Berghoff, A. S.
    Marhold, M.
    Bergen, E. S.
    Roider-Schur, S.
    Starzer, A. M.
    Forstner, H.
    Rottenmanner, B.
    Dieckmann, K.
    Bago-Horvath, Z.
    Widhalm, G.
    Ilhan-Mutlu, A.
    Minichsdorfer, C.
    Fureder, T.
    Singer, C.
    Weltermann, A.
    Preusser, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 73 - 73
  • [47] FINAL OUTCOME ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-POSITIVE BREAST CANCER PATIENTS WITH ACTIVE BRAIN METASTASES
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Furtner, Julia
    Marhold, Maximilian
    Bergen, Elisabeth Sophie
    Roider-Schur, Sophie
    Starzer, Angelika Maria
    Mair, Maximilian
    Forstner, Heidrun
    Rottenmanner, Beate
    Aretin, Marie-Bernadette
    Dieckmann, Karin
    Bago-Horvath, Zsuzsanna
    Haslacher, Helmuth
    Widhalm, Georg
    Ilhan-Mutlu, Aysegul
    Minichsdorfer, Christoph
    Fuereder, Thorsten
    Szekeres, Thomas
    Oehler, Leopold
    Gruenberger, Birgit
    Pfeiler, Georg
    Singer, Christian F.
    Weltermann, Ansgar
    Berchtold, Luzia
    Preusser, Matthias
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Furtner, Julia
    Marhold, Maximilian
    Bergen, Elisabeth Sophie
    Roider-Schur, Sophie
    Mair, Maximilian Johannes
    Starzer, Angelika Martina
    Forstner, Heidrun
    Rottenmanner, Beate
    Aretin, Marie-Bernadette
    Dieckmann, Karin
    Bago-Horvath, Zsuzsanna
    Haslacher, Helmuth
    Widhalm, Georg
    Ilhan-Mutlu, Ayseguel
    Minichsdorfer, Christoph
    Fuereder, Thorsten
    Szekeres, Thomas
    Oehler, Leopold
    Gruenberger, Birgit
    Pfeiler, Georg
    Singer, Christian
    Weltermann, Ansgar
    Berchtold, Luzia
    Preusser, Matthias
    NEURO-ONCOLOGY, 2024,
  • [49] Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial
    Lin, Nancy U.
    Murthy, Rashmi K.
    Abramson, Vandana
    Anders, Carey
    Bachelot, Thomas
    Bedard, Philippe L.
    Borges, Virginia
    Cameron, David
    Carey, Lisa A.
    Chien, A. Jo
    Curigliano, Giuseppe
    DiGiovanna, Michael P.
    Gelmon, Karen
    Hortobagyi, Gabriel
    Hurvitz, Sara A.
    Krop, Ian
    Loi, Sherene
    Loibl, Sibylle
    Mueller, Volkmar
    Oliveira, Mafalda
    Paplomata, Elisavet
    Pegram, Mark
    Slamon, Dennis
    Zelnak, Amelia
    Ramos, Jorge
    Feng, Wentao
    Winer, Eric
    JAMA ONCOLOGY, 2023, 9 (02) : 197 - 205
  • [50] Cyclin-dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in the Management of Brain Metastases in HR-positive/HER2-negative Breast Cancer Patients
    Kubeczko, Marcin
    Gabrys, Dorota
    Polakiewicz-Gilowska, Anna
    Krzywon, Aleksandra
    Graupner, Donata
    Lanoszka, Barbara
    Mianowska-Malec, Marta
    Lesniak, Aleksandra
    Swiderska, Katarzyna
    Chomik, Konstanty
    Grandys, Barbara
    Jarzab, Michal
    CANCER RESEARCH, 2024, 84 (09)
12345